The Editor-in-Chief is a member of the International Society of Addiction Journal Editors
Aims and Scope
The Journal of Cannabis Research is a fully open access, peer-reviewed journal that welcomes submissions covering all topics pertaining to cannabis. Our goal is to provide an outlet for experts across disciplines and foster innovation and collaboration, driving public discourse around this timely issue and furthering this exciting area of research.
Read the aims and scopeThe Two Sides of Hemp
Section Editor for Agriculture and Plant Biology, Dr Nirit Bernstein, is pleased to launch a collection titled, "The Two Sides of Hemp: Medical and Industrial". We cover hemp plant science; chemistry and cultivation; ethnobotany and regulations; medical and industrial uses of hemp and hemp products (such as cannabidiol); and differences between hemp and psychoactive cannabis.
-
-
High levels of pesticides found in illicit cannabis inflorescence compared to licensed samples in Canadian study using expanded 327 pesticides multiresidue method
-
Cannabis use for exercise recovery in trained individuals: a survey study
-
The COVID-19 pandemic and cannabis use in Canadaāa scoping review
-
DMSO potentiates the suppressive effect of dronabinol on sleep apnea and REM sleep in rats
-
Processing and extraction methods of medicinal cannabis: a narrative review
-
Delta-8-THC: Delta-9-THCās nicer younger sibling?
-
Ī9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
-
Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis
-
Total and differential white blood cell count in cannabis users: results from the cross-sectional National Health and Nutrition Examination Survey, 2005ā2016
Why publish with us?
Achieve high impact with a broad audience and publish in the leading open access cannabis research journal
- Impact Factor of 3.7, CiteScoreā¢ of 3.5 and mean 6.5k downloads/article
- Truly multidisciplinary covering all aspects of cannabis and led by an esteemed Editorial Board
- Broadly indexed and highly discoverable, including PubMed Central, Scopus, Web of Science and more...
Check our article-processing charges and find out how to get supported.
Truly multidisciplinary
Our journal welcomes all aspects of cannabis research, divided into the following sections:
- Agriculture and plant biology
- Commerce, business, and environment
- Endocannabinoid system
- Cannabis and cannabinoids biochemistry and genetics
- Cannabis and cannabinoids preclinical pharmacology
- Cannabis and cannabinoids clinical pharmacology
- Epidemiology and public health
- Cannabis-related disorders
- Medical cannabis
- History, regulation, and public policy
In Memoriam: Raphael Mechoulam
It is with great sadness that the Journal of Cannabis Research report the death of world-renowned cannabis researcher and our valued editorial board member, Raphael Mechoulam, PhD, on March 9, 2023.
Read a tribute from our Editor-in-Chief.
About the Institute
The Institute of Cannabis Research was established in June 2016 through an innovative partnership between Colorado State University Pueblo, the state of Colorado, and Pueblo County.
The ICR is the first US multi-disciplinary cannabis research center at a regional, comprehensive institution. The primary function of the Institute is the generation of knowledge that contributes to science, medicine, and society through investigation of the benefits and risks associated with cannabis. Research findings are used to translate discoveries into innovative applications that improve lives.
Journal of Cannabis Research is published in partnership with Colorado State University - Pueblo's Institute of Cannabis Research.
Visit the websiteAbout the Editor-in-Chief
David A. Gorelick, MD, PhD, DLFAPA, is Professor of Psychiatry (part-time) at the University of Maryland School of Medicine, having retired in October 2013 from the Intramural Research Program of the National Institute on Drug Abuse (NIDA), US National Institutes of Health (NIH) in Baltimore, Maryland.
Dr Gorelick's research interests are the clinical pharmacology of substance use, substance withdrawal, and biological treatments of substance use disorders. His recent work focuses on cannabis (including its potential therapeutic uses), cocaine, and individuals with co-morbid psychiatric disorders.
Read moreAffiliated with
āāāāāāāAn official publication of the Institute of Cannabis Research
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
3.4 - 5-year Impact Factor
0.741 - SNIP (Source Normalized Impact per Paper)2022 Speed
7 days submission to first editorial decision for all manuscripts (Median)
302 days submission to accept (Median)2022 Usage
672,036 downloads
3,864 Altmetric mentions